Drug comparisons
Acarbose vs Pioglitazone
Compare Acarbose (Precose) vs Pioglitazone (Actos) for type 2 diabetes: GI postprandial effects vs TZD insulin sensitizer with HF and weight-gain risks.
No comparison dimensions are available for this page.
Clinical context
Type 2 diabetes patients weighing an inexpensive oral postprandial agent against a thiazolidinedione insulin sensitizer that improves insulin resistance but risks heart failure and weight gain.
Bottom line
Pioglitazone generally delivers greater efficacy and insulin sensitization while Acarbose remains a simple oral choice with mainly GI effects, so selection is highly individualized.
All medication comparisons